Asparlas
Chemical Name | calaspargase pegol-mknl |
Dosage Form | Injection (intravenous; 3,750 units/5 mL) |
Drug Class | Enzymes |
System | Blood |
Company | Servier Pharmaceuticals LLC. |
Approval Year | 2018 |
Indication
- Indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years.